Colossal Biosciences Funding & Investors
Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics.
colossal.comTotal Amount Raised: $235,500,000
Colossal Biosciences Funding Rounds
Series B
$150,000,000
Series B Investors
US Innovative Technology FundBold Capital PartnersBreyer CapitalIn-Q-TelAnimoca BrandsBob NelsenJazz Venture PartnersWestRiver GroupVictor VescovoAnimal CapitalPEAK6Elias إلياس אֱלִיָּהוּ 以利亚Wave Digital AssetsSeries Unknown
$10,500,001
Series A
$60,000,000
Series A Investors
At One VenturesThomas TullBuilders VCCharles HoskinsonFirst Light CapitalJazz Venture PartnersAnimal CapitalBold Capital PartnersBoost VCBreyer CapitalRobert NelsenDraper AssociatesGreen Sands EquityParis HiltonAnimoca BrandsUntamed PlanetcFundMilad Alucozai11:11 MediaSeed
$15,000,000
Seed Investors
Thomas TullTony RobbinsCapital FactoryClimate CapitalJeffrey WilkeGlobal Space VenturesWinklevoss CapitalDraper AssociatesAnimal CapitalLiquid 2 VenturesAt One VenturesFirst Light CapitalJazz Venture PartnersBreyer CapitalBold Capital PartnersRayyan IslamKittyHawk Ventures
Funding info provided by Diffbot.